Medtronic Reaffirms Commitment to China Market at Five-Year Anniversary of CIIE Participation

ShanghaiSeptember 16, 2022PR Newswire -- With 50 days to go before the Fifth China International Import Expo (hereinafter referred to as "CIIE"), Medtronic, as the vice chairman unit of the CIIE Medical Device Professional Committee, will showcase over 70 innovative products under the theme "Insight into Life, Create the Extraordinary" at this year's CIIE. The exhibits will focus on the global medical technology trends of intelligence, minimally invasive procedures, and human-centered approaches, as well as personalized services, conveying Medtronic's vision of creating extraordinary life experiences through innovative technology.

Walking alongside the CIIE for five years, Medtronic has leveraged the strong influence and spillover effects of the CIIE platform to accelerate the implementation of innovative achievements in China, truly realizing the transformation from "exhibits to products." At this year's CIIE, Medtronic will showcase several star products that are "spillover results of the CIIE," including: the Micra VR and Micra AV Transcatheter Leadless Pacemaker Systems, the CoreValve Evolut PRO Transcatheter Aortic Valve Replacement System, the MAZOR X Spine Surgery Navigation and Positioning System, and more, sharing Medtronic’s CIIE story and China story with all sectors of society.

Medtronic's "Robotics Showcase" to Debut at This Year's CIIE -- The First Simultaneous Exhibition in China of Robotic-Assisted Surgical Solutions for Various Surgical Scenarios. Among them, the Hugo RAS System Robotic-Assisted Surgery System.^*Will make its "China debut" at the CIIE. Its more flexible, more compatible, more intelligent, and more accessible features will provide better medical solutions for patients. Along with the MAZOR X Spine Surgery Navigation and Positioning System and the Stealth Autoguide Neurosurgical Positioning System.^*The three major surgical assistant robots will comprehensively showcase Medtronic's significant innovative achievements in the application of artificial intelligence in healthcare scenarios at the CIIE.

The "Five-Year Promise" of the CIIE sends a positive signal to society and enterprises, and also provides Medtronic with a valuable opportunity to accurately seize opportunities in China. "With over thirty years of deep cultivation in China, Medtronic's confidence in the Chinese market has always been firm. As a witness and participant in the rapid development of China's medical technology industry, we continue to strengthen local innovation and value chain construction in this new era. Leveraging Medtronic's global innovation advantages and comprehensive local capabilities in China, we accelerate the introduction of high-quality, accessible, and affordable medical solutions, fulfilling Medtronic's unwavering commitment to patients and healthcare providers in China."Medtronic Global Senior Vice President and Greater China President Gu Yushao"This year marks the fifth year that Medtronic has participated in the CIIE. We look forward to leveraging the CIIE's strong influence and spillover effects to promote international exchange and cooperation in the medical industry, advance together with China's healthcare sector, and contribute to the realization of the ‘Healthy China’ vision."

*The product has not been registered for marketing in China.